161 related articles for article (PubMed ID: 32088302)
1. Multiple Cycles of Granulocyte Colony-Stimulating Factor Increase Survival Times of Patients With Decompensated Cirrhosis in a Randomized Trial.
De A; Kumari S; Singh A; Kaur A; Sharma R; Bhalla A; Sharma N; Kalra N; Singh V
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):375-383.e5. PubMed ID: 32088302
[TBL] [Abstract][Full Text] [Related]
2. Multiple cycles of granulocyte colony-stimulating factor in decompensated cirrhosis: a double-blind RCT.
Venkitaraman A; De A; Verma N; Kumari S; Leishangthem B; Sharma RR; Kalra N; Grover S; Singh V
Hepatol Int; 2022 Oct; 16(5):1127-1136. PubMed ID: 35322373
[TBL] [Abstract][Full Text] [Related]
3. Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis.
Kedarisetty CK; Anand L; Bhardwaj A; Bhadoria AS; Kumar G; Vyas AK; David P; Trehanpati N; Rastogi A; Bihari C; Maiwall R; Garg HK; Vashishtha C; Kumar M; Bhatia V; Sarin SK
Gastroenterology; 2015 Jun; 148(7):1362-70.e7. PubMed ID: 25749502
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Granulocyte Colony-Stimulating Factor and N-Acetylcysteine Therapies in Patients With Severe Alcoholic Hepatitis.
Singh V; Keisham A; Bhalla A; Sharma N; Agarwal R; Sharma R; Singh A
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1650-1656.e2. PubMed ID: 29391265
[TBL] [Abstract][Full Text] [Related]
5. Outcomes after multiple courses of granulocyte colony-stimulating factor and growth hormone in decompensated cirrhosis: A randomized trial.
Verma N; Kaur A; Sharma R; Bhalla A; Sharma N; De A; Singh V
Hepatology; 2018 Oct; 68(4):1559-1573. PubMed ID: 29278428
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure.
Garg V; Garg H; Khan A; Trehanpati N; Kumar A; Sharma BC; Sakhuja P; Sarin SK
Gastroenterology; 2012 Mar; 142(3):505-512.e1. PubMed ID: 22119930
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial.
Newsome PN; Fox R; King AL; Barton D; Than NN; Moore J; Corbett C; Townsend S; Thomas J; Guo K; Hull D; Beard HA; Thompson J; Atkinson A; Bienek C; McGowan N; Guha N; Campbell J; Hollyman D; Stocken D; Yap C; Forbes SJ
Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):25-36. PubMed ID: 29127060
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte colony-stimulating factor improves survival of patients with decompensated cirrhosis: a randomized-controlled trial.
Prajapati R; Arora A; Sharma P; Bansal N; Singla V; Kumar A
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):448-455. PubMed ID: 27930386
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic implications of granulocyte colony stimulating factor in patients with acute-on-chronic liver failure: increased survival and containment of liver damage.
Saha BK; Mahtab MA; Akbar SMF; Noor-E-Alam SM; Mamun AA; Hossain SMS; Alam MA; Moben AL; Khondaker FA; Chowdhury FI; Raihan R; Rahman S; Choudhury AK;
Hepatol Int; 2017 Nov; 11(6):540-546. PubMed ID: 28840583
[TBL] [Abstract][Full Text] [Related]
10. Early cirrhosis and a preserved bone marrow niche favour regenerative response to growth factors in decompensated cirrhosis.
Anand L; Bihari C; Kedarisetty CK; Rooge SB; Kumar D; Shubham S; Kumar G; Sahney A; Sharma MK; Maiwall R; Kumar A; Sarin SK
Liver Int; 2019 Jan; 39(1):115-126. PubMed ID: 29962032
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicenter randomized trial (GRAFT study).
Engelmann C; Herber A; Franke A; Bruns T; Reuken P; Schiefke I; Zipprich A; Zeuzem S; Goeser T; Canbay A; Berg C; Trebicka J; Uschner FE; Chang J; Mueller T; Aehling N; Schmelzle M; Splith K; Lammert F; Lange CM; Sarrazin C; Trautwein C; Manns M; Häussinger D; Pfeiffenberger J; Galle PR; Schmiedeknecht A; Berg T
J Hepatol; 2021 Dec; 75(6):1346-1354. PubMed ID: 34364917
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure.
Duan XZ; Liu FF; Tong JJ; Yang HZ; Chen J; Liu XY; Mao YL; Xin SJ; Hu JH
World J Gastroenterol; 2013 Feb; 19(7):1104-10. PubMed ID: 23467275
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study.
Singh V; Sharma AK; Narasimhan RL; Bhalla A; Sharma N; Sharma R
Am J Gastroenterol; 2014 Sep; 109(9):1417-23. PubMed ID: 24935272
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte Colony-Stimulating Factor Use in Decompensated Cirrhosis: Lack of Survival Benefit.
Philips CA; Augustine P; Rajesh S; Ahamed R; George T; Padsalgi G; Paramaguru R; Valiathan G; John SK
J Clin Exp Hepatol; 2020; 10(2):124-134. PubMed ID: 32189927
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
16. CD34(+) cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis.
Nakamura T; Torimura T; Iwamoto H; Kurogi J; Inoue H; Hori Y; Sumie S; Fukushima N; Sakata M; Koga H; Abe M; Ikezono Y; Hashimoto O; Ueno T; Oho K; Okamura T; Okuda S; Kawamoto A; Ii M; Asahara T; Sata M
J Gastroenterol Hepatol; 2014 Oct; 29(10):1830-8. PubMed ID: 24731186
[TBL] [Abstract][Full Text] [Related]
17. Effects of Virologic Response to Treatment on Short- and Long-term Outcomes of Patients With Chronic Hepatitis B Virus Infection and Decompensated Cirrhosis.
Jang JW; Choi JY; Kim YS; Yoo JJ; Woo HY; Choi SK; Jun CH; Lee CH; Sohn JH; Tak WY; Lee YR; Han KH
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1954-1963.e3. PubMed ID: 29753085
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial.
Spahr L; Lambert JF; Rubbia-Brandt L; Chalandon Y; Frossard JL; Giostra E; Hadengue A
Hepatology; 2008 Jul; 48(1):221-9. PubMed ID: 18537187
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-colony stimulating factor in decompensated liver cirrhosis: a meta-analysis of four randomized controlled trials.
Dimachkie R; Hamadi R; Alameddine Z; Aridi H; Sakr F; Asmar S; Deeb L
Eur J Gastroenterol Hepatol; 2023 Dec; 35(12):1382-1388. PubMed ID: 37642669
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial.
Cho Y; Park YS; Kim HY; Kim W; Lee HJ; Kim DJ
Trials; 2018 Dec; 19(1):696. PubMed ID: 30577864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
